Jane Street Group LLC cut its position in Cross Country Healthcare, Inc. (NASDAQ:CCRN - Free Report) by 84.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 27,808 shares of the business services provider's stock after selling 153,684 shares during the period. Jane Street Group LLC owned about 0.08% of Cross Country Healthcare worth $505,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Other large investors also recently modified their holdings of the company. Quadrant Capital Group LLC purchased a new stake in Cross Country Healthcare during the fourth quarter valued at approximately $25,000. Plato Investment Management Ltd purchased a new position in Cross Country Healthcare during the fourth quarter valued at approximately $46,000. Mint Tower Capital Management B.V. bought a new position in shares of Cross Country Healthcare in the 4th quarter worth $182,000. Guggenheim Capital LLC bought a new position in shares of Cross Country Healthcare in the 4th quarter worth $201,000. Finally, Envestnet Asset Management Inc. purchased a new stake in Cross Country Healthcare during the fourth quarter valued at approximately $217,000. Hedge funds and other institutional investors own 96.03% of the company's stock.
Cross Country Healthcare Price Performance
Shares of CCRN stock traded down $0.11 on Friday, hitting $13.22. The stock had a trading volume of 374,375 shares, compared to its average volume of 583,687. The company's 50 day moving average price is $14.07 and its 200-day moving average price is $15.66. Cross Country Healthcare, Inc. has a 1 year low of $9.58 and a 1 year high of $18.50. The firm has a market capitalization of $433.39 million, a P/E ratio of -264.35, a P/E/G ratio of 3.32 and a beta of 0.38.
Cross Country Healthcare (NASDAQ:CCRN - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The business services provider reported $0.06 EPS for the quarter, beating analysts' consensus estimates of $0.04 by $0.02. Cross Country Healthcare had a negative net margin of 0.12% and a positive return on equity of 5.38%. The business's revenue was down 22.6% on a year-over-year basis. During the same period in the prior year, the firm posted $0.19 EPS. On average, equities analysts forecast that Cross Country Healthcare, Inc. will post 0.53 EPS for the current year.
Wall Street Analyst Weigh In
CCRN has been the subject of a number of research analyst reports. Wall Street Zen initiated coverage on shares of Cross Country Healthcare in a report on Thursday, May 15th. They issued a "hold" rating for the company. Barrington Research reissued a "market perform" rating and issued a $18.61 target price on shares of Cross Country Healthcare in a research report on Friday, March 14th. UBS Group cut their target price on Cross Country Healthcare from $18.61 to $16.50 and set a "neutral" rating on the stock in a research report on Tuesday, May 13th. Finally, JMP Securities reissued a "market perform" rating on shares of Cross Country Healthcare in a research report on Thursday, February 6th. Seven equities research analysts have rated the stock with a hold rating, According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $17.93.
View Our Latest Report on CCRN
About Cross Country Healthcare
(
Free Report)
Cross Country Healthcare, Inc provides talent management and other consultative services for healthcare clients in the United States. The company's Nurse and Allied Staffing segment provides traditional staffing, recruiting, and value-added total talent solutions, including temporary and permanent placement of travel and local nurse and, allied professionals; temporary placement of healthcare leaders within nursing, allied, physician, and human resources; vendor neutral and managed services programs; education healthcare services; in-home care services; and outsourcing services.
Featured Stories

Before you consider Cross Country Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cross Country Healthcare wasn't on the list.
While Cross Country Healthcare currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.